U.S. Markets closed

What Are Analysts Recommending for Merck?

Margaret Patrick
What Are Analysts Recommending for Merck?

What to Expect from Merck’s Q1 2019 ResultsStock price movements On April 22, Merck (MRK) issued a press release announcing FDA approval for the combination of Keytruda with Pfizer’s (PFE) Inlyta in the first-line advanced RCC (renal cell